论文信息 - Protecting the Public's Health: Critical Functions of the Section 317 Immunization Program—A Report of the National Vaccine Advisory Committee - 字舞流文

Protecting the Public's Health: Critical Functions of the Section 317 Immunization Program—A Report of the National Vaccine Advisory Committee

Iris R. Mabry-Hernandez | Angela K. Shen | K. Viswanath | A. Schuchat | R. Lynfield | Y. Maldonado | M. Wharton | Litjen Tan | B. Gellin | M. Grabowsky | R. Daum | J. Kelman | W. Orenstein | R. Beigi | T. Buck | S. Despres | P. LaRussa | J. Morita | Charles P. Mouton | A. Pisani | M. Rothholz | T. Stenvig | C. Torres | S. Hetherington | Clement Lewin | A. Bailowitz | C. Baker | Charlene Douglas | Claire Hannan | P. Jarris | Wayne S. Rawlins | V. Richardson | D. Salisbury | M. Burke | R. Church | Geoffrey C. Evans | M. Gruber | R. Hill | R. Martinello | Margaret M McCluskey | Barbara Mulach | Col Scott A. Stanek | T. Dwelle | P. Etkind | A. Groom | Kristin Pope | Candice Swartwood | K. Talkington | Vesta L Richardson | Litjen L J Tan

[1] L. Wang,et al. Economic Evaluation of the Routine Childhood Immunization Program in the United States, 2009 , 2014, Pediatrics.

[2] S. Stokley,et al. Middle School Vaccination Requirements and Adolescent Vaccination Coverage , 2012, Pediatrics.

[3] Angela K. Shen,et al. Strengthening the U.S. Vaccine and Immunization Enterprise: The Role of the National Vaccine Advisory Committee , 2011, Public health reports.

[4] L. Pabst. Invasive pneumococcal disease and 13-valent pneumococcal conjugate vaccine (PCV13) coverage among children aged ≤59 months---selected U.S. regions, 2010--2011. , 2011, MMWR. Morbidity and mortality weekly report.

[5] W. Bellini,et al. Measles in the United States during the postelimination era. , 2010, The Journal of infectious diseases.

[6] W. Schaffner,et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. , 2010, The Journal of infectious diseases.

[7] T. Murphy,et al. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. , 2007, JAMA.

[8] D. Rein,et al. Impact of the CDC's Section 317 Immunization Grants Program funding on childhood vaccination coverage. , 2006, American journal of public health.

[9] G. Garnett,et al. ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES , 2006 .

[10] A. Hinman,et al. Summary and conclusions: measles elimination meeting, 16-17 March 2000. , 2004, The Journal of infectious diseases.

[11] L. Barker,et al. National, state and urban-area vaccination-coverage levels among children aged 19-35 months, United States, 1999. , 2001, American journal of preventive medicine.

[12] Robert T. Chen,et al. Population-based study of rotavirus vaccination and intussusception , 2001, The Pediatric infectious disease journal.

[13] M. Wasserman,et al. Guide to community preventive services: state and local opportunities for tobacco use reduction. , 2001, American journal of preventive medicine.

[14] L. Harrison,et al. Active bacterial core surveillance of the emerging infections program network. , 2001, Emerging infectious diseases.

[15] Cynthia G. Whitney,et al. Preventing pneumococcal disease among infants and young children : recommendations of the Advisory Committee on Immunization Practices (ACIP) , 2000 .

[16] Prevots Dr,et al. Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2000 .